2021-08-26 14:27:55
Nigeria recently approved China’s Sinopharm COVID-19 vaccine, Dr. Faisal Shuaib, director of Nigeria’s National Primary Health Care Development Agency, said on August 24. About 7.7 million doses of the vaccine have been allocated to Nigeria under the COVAX program, which aims to provide vaccines to developing countries. The Nigerian official did not specify when the Sinopharm doses would arrive or be administered.
ReadBeyond Covid, vaccine equity must become the norm
Cases are on the rise in Nigeria, with new daily infections up tenfold from levels seen in July, according to an agency tally Archyde.com.
Nigeria, Africa’s most populous country with some 200 million people, vaccinated only a small proportion of them, largely due to a lack of supply. So far, some 2 million people, or 1% of the population, have received one dose of the vaccine, while less than a million have received two.
Undervalued contaminations
The deployment of vaccines, which had been interrupted on July 9 due to the depletion of stocks following an initial phase, resumed on August 16.
During the first phase, Nigeria used doses of the AstraZeneca vaccine received through COVAX. He has since received Moderna vaccine doses donated by the United States, which are being used for the second phase.
ReadCovid-19: what you need to know to travel to France from the Maghreb
Johnson & Johnson vaccines purchased by Nigeria through an African Union program are also expected to be used. According to official data, Nigeria has recorded 187,588 COVID-19 cases and 2,276 deaths since the start of the pandemic, but the figures might be much higher given that only 2.7 million samples have been tested.
1689179523
#Nigeria #receive #million #doses #Chinese #Sinopharm #vaccine #Jeune #Afrique
